European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

Journal of the Peripheral Nervous System : JPNS
Joint Task Force of the EFNS and the PNS

Abstract

Paraprotein-associated neuropathies have heterogeneous clinical, neurophysiological, neuropathological, and hematological features. The aim of this guideline was to prepare evidence-based and consensus guidelines on the clinical management of patients with both a demyelinating neuropathy and a paraprotein [paraproteinemic demyelinating neuropathy (PDN)]. Disease experts and a representative of patients considered references retrieved from MEDLINE and the Cochrane Library and prepared statements that were agreed in an iterative fashion. In the absence of adequate data, evidence-based recommendations were not possible, but the Task Force agreed on the following good practice points: (1) patients with PDN should be investigated for a malignant plasma cell dyscrasia; (2) the paraprotein is more likely to be causing the neuropathy if the paraprotein is immunoglobulin M (IgM), antibodies are present in serum or on biopsy, or the clinical phenotype is chronic distal sensory neuropathy; (3) patients with IgM PDN usually have predominantly distal and sensory impairment, with prolonged distal motor latencies, and often anti-myelin-associated glycoprotein antibodies; (4) IgM PDN sometimes responds to immunotherapies. Their potential benef...Continue Reading

References

Jun 1, 1992·Neurology·R Diaz-ArrastiaL P Rowland
Nov 21, 1991·The New England Journal of Medicine·P J DyckB A Evans
Jan 1, 1981·Neurology·J J KellyP J Dyck
Mar 1, 1982·The British Journal of Radiology·H LudwigH Sinzinger
May 1, 1996·Muscle & Nerve·L Van den BergN Latov
Jul 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·T MaisonobeP Bouche
Apr 8, 1998·Acta Neurologica Scandinavica·D SimovicA H Ropper
May 29, 1998·The New England Journal of Medicine·A H Ropper, K C Gorson
Mar 2, 1999·Archives of Pathology & Laboratory Medicine·D F Keren
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H C WilsonR A Hughes
Feb 19, 2000·Neurology·J S KatzR J Barohn
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara CesanaEnrica Morra
Mar 19, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Margherita CapassoAntonino Uncini
Sep 5, 2002·Muscle & Nerve·Jia-Ying SungTakamichi Hattori
Oct 17, 2002·Journal of Neurology·Giancarlo ComiUNKNOWN Inflammatory Neuropathy Cause and Treatment Group
Oct 23, 2002·Neurology·Amitabha GhoshMichael Donaghy
Nov 29, 2002·Blood·Angela DispenzieriMorie A Gertz
Jan 30, 2003·Ultrastructural Pathology·Claude VitalKlaus G Petry
Mar 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A PestronkT D Levine
Apr 23, 2003·Muscle & Nerve·Susanne RenaudAndreas J Steck
Apr 30, 2003·Seminars in Oncology·Roger G Owen
Dec 4, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L MagyJ-M Léger
Jun 5, 2004·Journal of the Neurological Sciences·M M MehndirattaB K Bajaj
Sep 24, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M BraininUNKNOWN Guideline Standards Subcommittee of the EFNS Scientific Committee

❮ Previous
Next ❯

Citations

Feb 3, 2007·Der Nervenarzt·H C LehmannB C Kieseier
Sep 20, 2008·Journal of Neurology·Richard Hughes
Mar 3, 2009·Journal of Neurology·Raffaele IorioGabriella Silvestri
Nov 18, 2011·Current Neurology and Neuroscience Reports·Sindhu Ramchandren, Richard A Lewis
Sep 16, 2010·Current Treatment Options in Neurology·Marinos C Dalakas
Jul 31, 2013·Neurocritical Care·Axel Petzold, Armand Girbes
Jun 25, 2013·Trends in Pharmacological Sciences·Mathias ButtmannHans-Peter Hartung
Oct 30, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register
Feb 18, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y A Rajabally, S Samarasekera
Jun 22, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C PazzagliaL Padua
Jul 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y A Rajabally, M Narasimhan
Jan 5, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S LarueJ M Léger
Jan 12, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A B BohnM E Hokland
Aug 9, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register
Dec 6, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y A RajaballyG Nicolas
Mar 21, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·Steven AustinNick Losseff
Jul 14, 2009·Molecular Medicine·Andreas A Argyriou
Jul 26, 2011·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Toshio Ariga
Jul 29, 2009·Leukemia & Lymphoma·Sasa A ZivkovićSuzanne Lentzsch
Jun 18, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Gabriella ZaraM Ermani
Oct 19, 2011·Journal of the Peripheral Nervous System : JPNS·Berengere GrusonBruno Royer
Jan 13, 2015·Annals of Hematology·Giampaolo TalamoDivisha Raheja
Mar 8, 2013·Gait & Posture·Besma Missaoui, Philippe Thoumie
Feb 22, 2017·Autoimmunity Reviews·Alberto R M MartinezMarcondes C França
Jun 26, 2010·Bone Marrow Transplantation·H D HummelM S Topp
Sep 22, 2007·Current Opinion in Neurology·Pierre Lozeron, David Adams
Jul 8, 2008·Journal of the Peripheral Nervous System : JPNS·Richard A C Hughes
Jul 25, 2009·Current Opinion in Neurology·Sindhu Ramchandren, Richard A Lewis
Nov 3, 2006·Expert Review of Neurotherapeutics·Yee-Cheun Chan, Einar Wilder-Smith
Dec 2, 2014·Journal of Physical Therapy Science·Hideyuki Nakae, Hitoshi Tsushima
Jun 24, 2006·Blood·Giampaolo Merlini, Marvin J Stone
Sep 5, 2008·Current Opinion in Neurology·Pieter A van Doorn, Ingemar S J Merkies
Mar 20, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H C LehmannB C Kieseier
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Laurent Magy, Jean-Michel Vallat
May 6, 2010·Expert Review of Clinical Immunology·Eduardo A De Sousa
Jul 19, 2014·Practical Neurology·A NeliganM P Lunn
Dec 20, 2011·Journal of the Peripheral Nervous System : JPNS·Elspeth J HuttonMary M Reilly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.